He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...
"[Doctors should] be informed that hair loss may be a potential side effect." "With this information, the risk-benefit trad ...
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
They’re expensive and aren’t a short-term fix, but Ozempic and Wegovy show great promise in regulating weight. | Opinion ...
The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...
A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...
Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. The launch ...
Packets of Wegovy move along the line at ... That risk was twice as high for women as for men. Read More: The Health Risks and Benefits of Weight-Loss Drugs While it’s not clear why semaglutide ...